Plant Biotechnology Equipment Market Report 2026

The plant biotechnology equipment market size has grown strongly in recent years. It will grow from $16.55 billion in 2025 to $17.76 billion in 2026 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to increasing investments in agricultural biotechnology research, expansion of plant genetic engineering programs, rising demand for disease-resistant crops, growth of academic and institutional research, availability of advanced laboratory instrumentation.

The plant biotechnology equipment market size is expected to see strong growth in the next few years. It will grow to $23.85 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing adoption of precision agriculture biotechnology, rising focus on climate-resilient crop development, expansion of commercial plant biotech applications, growing integration of automation in research labs, increasing demand for sustainable crop enhancement technologies. Major trends in the forecast period include increasing adoption of advanced tissue culture systems, rising use of gene editing and crispr tools, growing integration of automated bioreactors, expansion of high-throughput plant analysis equipment, enhanced focus on precision crop improvement.

Government funding for agricultural research is expected to drive the growth of the plant biotechnology equipment market going forward. Such funding refers to financial support provided by national or regional governments to promote research and development in agriculture, with the goal of improving productivity, sustainability, and innovation in farming practices. Investment in agricultural research is increasing due to the need to ensure food security amid challenges like climate change. The plant biotechnology equipment market benefits from this support by providing essential tools and technologies that facilitate advanced crop development, research efficiency, and innovation. For instance, in July 2025, according to the Department for Environment, Food & Rural Affairs (DEFRA), a UK-based government department, total funding to the agricultural industry rose to £4.42 billion ($5,441 million) in 2024, marking a 3.4% increase, while agri-environment scheme payments surged 51% to £1.12 billion. Therefore, government support for agricultural research is fueling growth in the plant biotechnology equipment market.

Companies in the plant biotechnology equipment market are increasingly focusing on innovations such as cell culture systems and cultivation-free bioprocessing platforms to improve production consistency and scalability of plant-derived compounds. For example, plant cell suspension culture with molecular fingerprint replication is a method where plant cells are grown in liquid media to produce compounds that accurately replicate the molecular profile of the source plant. In March 2025, PHC Corporation of North America, a US-based laboratory equipment provider, launched the PHCbi MCO-171AICUVD-PA high-heat CO₂ incubator. The system features an antimicrobial inCu-saFe interior combining copper’s germicidal properties with stainless steel durability, a Safe Cell UV-LED germicidal bulb, and an optional 11-hour high-heat sterilization cycle for decontamination. Such advanced incubation technologies enhance sterility, consistency, and reliability in plant biotechnology workflows.

In May 2025, Brookfield Corporation, a Canada-based investment management firm, and Quebec Deposit and Investment Fund, a Canada-based pension fund company, acquired Antylia Scientific for $1.34 billion. This acquisition aims to strengthen Antylia Scientific’s growth in the life sciences sector by improving its commercial strategy and procurement processes. Antylia Scientific is a US-based instrumentation company offering a wide range of laboratory equipment suitable for plant biotechnology applications.

Major companies operating in the plant biotechnology equipment market are Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., QIAGEN N.V., PerkinElmer Inc., Waters Corporation, Sartorius AG, Bruker Corporation, Eppendorf AG, Oxford Nanopore Technologies plc, Hamilton Company, Shimadzu Corporation, Corning Incorporated, Analytik Jena GmbH+Co. KG, Photon Systems Instruments, Labconco Corporation, Memmert GmbH, Esco Lifesciences Group Ltd., Qubit Systems Inc., LemnaTec GmbH.

North America was the largest region in the plant biotechnology equipment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the plant biotechnology equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the plant biotechnology equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the plant biotechnology equipment market by increasing costs of imported bioreactors, chromatography systems, centrifuges, sensors, and molecular analysis instruments. Research institutions and biotechnology companies in North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher costs in equipment sourcing and exports. These tariffs are increasing research capital expenditure and slowing lab expansion plans. However, they are also promoting domestic equipment manufacturing, regional supplier development, and localized innovation in plant biotechnology instrumentation.

The plant biotechnology equipment market research report is one of a series of new reports that provides plant biotechnology equipment market statistics, including plant biotechnology equipment industry global market size, regional shares, competitors with a plant biotechnology equipment market share, detailed plant biotechnology equipment market segments, market trends and opportunities, and any further data you may need to thrive in the plant biotechnology equipment industry. This plant biotechnology equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Plant biotechnology equipment refers to specialized instruments and tools used in plant research, development, and production through biotechnological methods. These include tissue culture systems, bioreactors, gene-editing tools, and analytical devices that support plant propagation, genetic modification, and disease-resistance studies. Such equipment enables precise manipulation, monitoring, and analysis of plant cells, tissues, and genes to improve crop traits, boost productivity, and advance sustainable agricultural solutions.

The main types of plant biotechnology equipment are bioreactors, fermenters, incubators, centrifuges, and chromatography systems. Bioreactors are engineered systems that provide controlled environments for the growth of cells, tissues, or microorganisms, optimizing biological processes, enhancing productivity, and supporting both research and industrial-scale applications. The technologies employed include CRISPR tools, next-generation sequencing, and polymerase chain reaction (PCR) techniques. These systems are applied in genetic engineering, plant tissue culture, molecular farming, biopesticide production, and biofertilizer development, serving end-users across agriculture, research institutions, biotechnology companies, pharmaceutical companies, and the food and beverage industry.

The plant biotechnology equipment market consists of revenues earned by entities by providing services such as tissue culture propagation, genetic engineering support, plant transformation and regeneration, micropropagation, cryopreservation, and molecular analysis of plant cells and tissues. The market value includes the value of related goods sold by the service provider or included within the service offering. The plant biotechnology equipment market also includes sales of gene sequencers, polymerase chain reaction systems, electrophoresis equipment, microarray systems, and plant tissue culture chambers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.